Latest filing published 14 May 2012 for Valeant Pharmaceuticals International, Inc., €163.
No signal scores available.
Richard Kevin Masterson is a declared insider of Valeant Pharmaceuticals International, Inc., with filings sourced from SEDI. In total, 8 filings cover trades dated from 26 April 2011 to 10 May 2012.
On the market, this insider has only sold: 1 sale, €163 in total. The rest of the record consists of 5 share grants and 2 option exercises. So far in 2012, the count stands at no purchases and 1 sale.
The record was last updated on 14 May 2012 with an open-market sale (€163) in Valeant Pharmaceuticals International, Inc. Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations